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lsevier1. Introduction
Cervical cancer is a leading cause of mortality and morbidity
after breast cancer; representing approximately 12% of all can-
cers in women worldwide [1]. In developing countries, it is the
most common gynecological cancer and one of the leading
causes of cancerous death amongst women [2]. In fact, annual
global statistics estimated 470,600 new cases and 233,400 deaths
from cervical cancer around the year 2000 [1]. However, cervical
cancer progression may take over a period of two to three dec-
ades to progress from pre-malignancy to invasive and/or meta-
static state [3,4]. Hence, the incidence and mortality related to
this disease can be signiﬁcantly reduced through early detection
and proper treatment [5,6]. However, the current methods (i.e.
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cal cancer are time-consuming and dependent on the skill of the
cytopathologist, thus is a rather subjective [7–10]. Conse-
quently, the failure of identifying or interpreting the specimens
correctly could occur.
As of now, the morphological changes of the cells (i.e. pat-
tern, structure, color and shape) are observed by pathologists
to screen any abnormalities of cervical cells. Human limitation
in visualization such as over-burden due to the limited number
of pathologists available and eye fatigue may lead to incorrect
diagnosis. Consequently, computer-aided screening or diag-
nostic system based on neural network could be a promising
tool to produce a more accurate and faster screening and/or
diagnostic result for cancer patients. This system provides a
second opinion for radiologists and pathologists. In 1984,
the International Academy of Cytology (IAC) Committee on
Automated Cytology reported the ﬁrst set of standards for a
model-automated cervical screening system [8]. Then, a num-
ber of researches were carried out speciﬁcally with the attempts
to automate both the Pap smear and the LBC classiﬁcation
based on artiﬁcial neural network (ANN) [8,9,11]. Several neu-
ral networks such as Multilayered Perceptron (MLP), Radial
Basis Function (RBF) and Hierarchical Hybrid Multilayered
Perceptron (H2MLP) had been recently applied to classify
the cervical pre-cancerous cells [12–15. The classiﬁcation re-
quires cervical cell features to be extracted manually by human
expert from the Pap smear and the LBC image as the input
data. The automated classiﬁcation system may not only reduce
the time required for sample classiﬁcation, but also reduce the
misclassiﬁcation of sample due to eye fatigue or human error
[10].
On the other hand, FTIR spectroscopy has been utilized as
an emerging method applied to the study of the structural
changes of cells at the molecular level in various human can-
cers. Over the past decades, there have been a number of stud-
ies done to investigate the possibility of the FTIR technique as
a screening tool for cervical cancer [16–21]. Inspired by the
outstanding results, many researchers have worked to explore
and apply the FTIR spectroscopy as a diagnostic tool for dif-
ferentiating normal and malignant tissues and cells of several
human cancers; including esophagus [22], colon [23], [24], skin
[25], gastric [26], lung [27], gliomas [28,29], and cervical cancers
[4,5,30–34]. The FTIR spectroscopy results are capable to
show the structural changes of the cells at the molecular level
in various human cancers. The structural changes are result of
carcinogenesis caused by different modes of vibration in the
molecules of the cells and tissues. The unique vibrational fre-
quencies of major functional groups are characterized by the
changes in the FTIR spectra. Thus, the FTIR spectra could
show normal or malignant cells with their spectral characteris-
tic appearance [17].
Studies done by El-tawil et al. [34] and Sindhuphak et al.
[32] further prove that FTIR could overcome the limitations
that exist either in the standard Pap smear or the LBC.
Those studies have made a notable discovery that the FTIR
technique has detected the changes at the molecular level via
structural change of certain functional groups instead of
detecting the morphological changes as used in the Pap
smear test. The FTIR spectra can be interpreted as normal
and abnormal results, based on the signiﬁcant changes in
the peak absorbance value ratios, and the shifts of the FTIR
peaks.Based on the limitation of the manual screening by human
expert and the capability of the cervical cells’ FTIR spectra, in
this study, we propose a screening system for pre-cancerous
cervical cells based on the FTIR spectra of cervical cells. The
proposed cervical cell features are extracted from cervical cells’
FTIR spectra using a new feature extraction algorithm called
the peak-corrected area-based features’ extraction (PCABFE).
These features will then be used as the input data for the ANN
to predict the cervical pre-cancerous stages. In the current
study, the HMLP network trained using a modiﬁed, recursive
prediction error (MRPE) algorithm is employed to classify the
cervical cells’ FTIR spectra into three categories based on the
Bethesda system (i.e. normal, the low grade intra-epithelial
squamous lesion (LSIL), and the high grade intra-epithelial
squamous lesion (HSIL)).
2. FTIR spectral data acquisition
The cervical cell samples used in this study are collected from
ThinPrep solution (PreservCyt; Cytyc, USA), which are ob-
tained from the Gribbles Pathology Laboratory Petaling Jaya,
Selangor, Malaysia (a private provider of diagnostic labora-
tory services in performing tests for all major disciplines of
pathology). The samples were taken from tissue biopsy of wo-
men undergoing routine cervical cancer screening in 2009. The
samples contained 590 normal, 150 LSIL, and 40 HSIL of
FTIR spectra. The FTIR spectra of cervical cells were ob-
tained by placing a small amount approximately 0.005 ml of li-
quid ThinPrep samples in a circular KRS5 window (an
infrared transparent cell). The liquid samples were dried using
a dryer for 2 to 3 min before the samples were induced by
infrared (IR) light.
The cervical cells’ FTIR spectra were collected using the
Spectrum BX II Fourier transform spectrometer (Perkin Elmer
type 2000, USA) equipped with deuterated-telluride-triglycine-
sulfate (DTGS) detector in mid IR region between 400 and
4000 cm1. The IR spectroscopic information was presented
in the form of a spectrum with the wavenumber as the x-axis
and the percentage of transmittance as the y-axis. The wave-
number is directly proportional to frequency as well as the en-
ergy of the sample. The more commonly used unit for
wavenumber in modern IR instruments is cm1, whereas, the
percentage of transmittance is not directly used in this study.
The spectral data obtained in the percent of transmittance
were converted to absorbance by using a FTIR spectroscopy
software (Spectrum version 5.0.1, Perkin Elmer, 2003) as
shown in Fig. 1.
By deﬁnition, absorbance (A) is the logarithm to the base 10
of the reciprocal of the transmittance (T) which is deﬁned as
Eq. (1). Transmittance, T, is the ratio of the transmitted inten-
sity (I) to the incident of the sample (I0) at a particular
frequency.
A ¼ log10
1
T
 
¼ log10T ¼ log10
I
I0
 
ð1Þ
In this study, the FTIR spectroscopy software was utilized
in data pre-processing. The pre-processing consists of smooth-
ing, automatic baseline correction, and normalization. The
spectrum is applied with smoothing and automatic baseline
correction processes before it is normalized to a minimum
Figure 1 The differences of normal, LSIL, and HSIL cervical
cells’ FTIR spectra in prominent bands using the FTIR
spectroscopy.
Table 1 Range of wavenumbers for peak absorbance value
determination of biochemical components of FTIR spectrum.
Biochemical components for
peak absorbance value features
Wavenumber (cm1)
m n
Amide I 1654 1626
Amide II 1560 1532
C–H alkyl bending in proteins 1414 1393
Asymmetric PO34 stretching in
nucleic acids (NA II)
1248 1220
C–O stretching in carbohydrate 1170 1150
Symmetric PO34 stretching in
nucleic acids (NA I)
1082 1074
Glycogen 1035 1022
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These processes are aimed to remove spectral variation due
to the samples’ thickness.
3. Features extraction for cervical cell spectra
In previous studies, the wavenumber range used for analyzing
between normal, LSIL, and HSIL lies in the 950–1800 cm1 re-
gion [16,33–37]. As shown in Fig. 1, different types of cervical
cells show different spectrum patterns with different prominent
peaks in the speciﬁc bands. The prominent peaks represent the
absorption bands of biochemical components. Based on the
previous studies done by [5,16,17,34,35,38] and this current
study, there are several biochemical components detected in
the cervical cells’ FTIR spectra that could be used for the clas-
siﬁcation purpose as shown in Fig. 1. The biochemical compo-
nents are:
i. Amide I (NH2).
ii. Amide II (NH).
iii. C–H alkyl bending in proteins.
iv. Asymmetric phosphate (PO34 ) stretching in nucleic
acids (NA II),
v. C–O stretching in carbohydrates.
vi. Symmetric phosphate (PO34 ) stretching in nucleic acids
(NA I).
vii. Glycogen.
Based on Fig. 1, the absorbance value of the infrared bands
at 1025.00 cm1 decreases from normal to HSIL as a result of
a reduction of the glycogen level in the HSIL sample [16]. In
normal cervical cells and liver, the absorbance of glycogen le-
vel is prominently shown, but not for tissues with low glycogen
level such as the colon [16]. The band at 1080.04 cm1 is due to
the symmetric phosphate (PO34 ) stretching mode in nucleic
acids (NA I). Its peak absorbance value decreases after becom-
ing HSIL. The absorption peak from the C–O stretching mode
in the carbohydrate band exists in 1155.90 cm1. The pattern
of the absorption peak shows a decreasing value from normal
to HSIL. The band at 1237.17 cm1 is due to the asymmetric
phosphate stretching modes. The vibrations from phosphate
groups originate in the phosphodiester groups of nucleic acids(NA II). In cervical cells, this band is a relatively weak band
for abnormal cervical cells, but prominent in normal cervical
cells. The band at 1403.03 cm1 arises from CH alkyl bending
modes in proteins [16]. The strong bands at 1644.82 and
1538.96 cm1 represent amide I and amide II bands, respec-
tively, and originate from the vibrations of the amide groups
in proteins. The amide II band is shown to be relatively strong
in normal and LSIL cervical cells.
In order to extract those aforementioned features of the
FTIR spectra, this study proposes a peak-corrected area-based
features’ extraction (PCABFE) algorithm. The PCABFE ex-
tracts three primary features namely the absorbance of speciﬁc
peaks, the corrected area in speciﬁc regions, and the height of
slope between amide I and amide II. At ﬁrst, the absorbance
value of the peaks in certain band is computed. In LSIL and
HSIL cervical cells, the peaks are frequently shifted to higher
or lower wavenumber [34]. In this study, the peak refers to a
maximum absorbance value in a certain region. As tabulated
in Table 1, the certain region refers to a region between two
wavenumber values namely m and n. For example, as shown
in Fig. 1 and Table 1, the peak of amide I exists in the region
between wavenumber 1654 cm1 and 1626 cm1 denoted as m
and n, respectively. As identiﬁed from the 780 spectroscopic
data used in the current study and the previously reported
FTIR data [16,35,34], the range of wavenumber for the afore-
mentioned seven biochemical components are tabulated in
Table 1. Thus, these values are proposed to identify the peaks
of those biochemical components in the proposed PCABFE
algorithm. In the second part, the corrected areas in certain
regions as shown in Fig. 2 are calculated. From Fig. 2, a cor-
rected area is deﬁned as an area under the spectrum bordered
with baseline (a line to connect two base points). The two base
points (i.e. denoted as k and l) for the baseline in the corrected
area calculation are tabulated in Table 2. The last part, the
height of slope between amide I and amide II is then
calculated.
In overall, seven prominent peaks, ﬁve corrected areas un-
der the spectrum, and one height of slope between amide I and
amide II are extracted by the proposed PCABFE from the
spectra. These features refer as primary features. However,
the peak and the corrected areas cannot be possibly used as
features for differentiating the normal, LSIL, and HSIL of
FTIR spectra. This circumstance is caused by the different
quantity of cells smeared onto the KRS cell of the FTIR equip-
ment. During the ThinPrep procedure, the quantity of the cer-
vical cells taken is often not consistent. This affects the
absorbance value of the peaks. Therefore, the ratio of the peak
Figure 2 Proposed corrected area features of cervical cell
spectra.
64 Y. Jusman et al.absorbance value and ratio of corrected areas are proposed as
secondary features for the classiﬁcation of the cervical cell
spectra. Hence, 21 secondary features are derived from the ra-
tio of seven prominent peak absorbance value (PAV), and 10
secondary features are then derived from the ratio of ﬁve cor-
rected areas (CA). Thus, a total of 32 features (i.e. PAV pro-
teins /PAV NA I, PAV amide II/PAV NA I, PAV proteins/
PAV amide I, PAV amide II/PAV proteins, PAV amide I/
PAV NA II, PAV amide II/PAV NA II, PAV amide I/PAV
NA I, PAV NA II/PAV NA I, PAV amide I/PAV carbohy-
drates, amide II/PAV carbohydrates, PAV amide I/PAV gly-
cogen, PAV proteins/PAV glycogen, PAV NA II/PAV
glycogen, PAV carbohydrates/PAV NA I, PAV carbohy-
drates/PAV Glycogen, PAV proteins/PAV NA II, PAV pro-
teins/PAV carbohydrates, PAV NA II/PAV carbohydrates,
PAV amide II/PAV glycogen, PAV NA I/PAV glycogen, CA
amide I/CA amide II, CA proteins/CA NA I, CA amide II/
CA NA I, CA proteins/CA amide I, CA amide II/CA proteins,
CA amide I/CA NA II, CA amide II/CA NA II, CA protein/
CA NA II, CA amide I/CA NA I, CA NA II/CA NA I, Height
of slope) are proposed as possible features of this FTIR spectra
to be used for the classiﬁcation purpose.
Based on the aforementioned explanation, the PCABFE
algorithm could be implemented as follow:
1. Obtain the secondary features from peak absorbance
value (PAV) based on the following steps:
i. Consider the region of amide I based on the range from
the wavenumber m to the wavenumber n as listed in
Table 1.
ii. Find the maximum absorbance value in the range
obtained in (i) and denoted as the peak absorbance value
(PAV).Table 2 Base points for biochemical components of FTIR spectrum
Biochemical components for corrected areas features
Amide I
Amide II
C–H alkyl bending in proteins
Asymmetric PO34 stretching in nucleic acids (NA II)
Symmetric PO34 stretching in nucleic acids (NA I)iii. Repeat steps (i) to (ii) for other chemical groups (i.e.
amide II, CH alkyl bending in proteins, asymmetric
phospate stretching in nucleic acids (NA II), C–O
stretching in carbohydrate, symmetric phosphate
stretching in nucleic acids (NA I), and glycogen) as listed
in Table I.
iv. Calculate the ratio of:
a. PAV proteins/PAV NA I
b. PAV amide II/PAV NA I
c. PAV proteins/PAV amide I
d. PAV amide II/PAV proteins
e. PAV amide I/PAV NA II
f. PAV amide II/PAV NA II
g. PAV amide I/PAV NA I
h. PAV NA II/PAV NA I
i. PAV amide I/PAV carbohydrates
j. PAV amide II/PAV carbohydrates
k. PAV amide I/PAV glycogen
l. PAV proteins/PAV glycogen
m. PAV NA II/PAV glycogen
n. PAV carbohydrates/PAV NA I
o. PAV carbohydrates/PAV Glycogen
p. PAV proteins/PAV NA II
q. PAV proteins/PAV carbohydrates
r. PAV NA II/PAV carbohydrates
s. PAV amide II/PAV glycogen
t. PAV NA I/PAV glycogen
2. Determine the secondary features from corrected areas
based on the following steps:
i. Determine two base points (i.e. k and l) of amide I as
tabulated in Table 2.
ii. Draw a straight line connecting those base points and
denoted as baseline as shown in Fig. 2.
iii. Calculate the area under spectrum for the region bor-
dered by the two base points which are denoted as As.
iv. Calculate the area under the baseline and denoted as Ab.
v. Calculate the corrected area (CA) of amide I using Eq.
(2).
CA ¼ As  Ab ð2Þ
i. Repeat steps (i)–(v) for each corrected area as shown in
Fig. 2.
ii. Calculate the ratio of:
a. CA amide I/CA amide II
b. CA proteins/CA NA I
c. CA amide II/CA NA I
d. CA proteins/CA amide I
e. CA amide II/CA proteins
f. CA amide I/CA NA II.
Wavenumber (cm1)
k l
1750 1580
1580 1484
1484 1273
1273 1182
1182 950
Table 3 The 32 features of the cervical cell of the FTIR
spectra.
Features Abbreviation
CA amide I/CA amide II (r1c) x1
CA proteins/CA NA I (r2c) x2
CA amide II/CA NA I (r3c) x3
CA proteins/CA amide I (r4c) x4
CA amide II/CA proteins (r5c) x5
CA amide I/CA NA II (r6c) x6
CA amide II/CA NA II (r7c) x7
CA protein/CA NA II (r8c) x8
CA amide I/CA NA I (r9c) x9
CA NA II/CA NA I (r10c) x10
PAV amide I/PAV amide II (r1p) x11
PAV proteins/PAV NA I (r2p) x12
PAV amide II/PAV NA I (r3p) x13
PAV proteins/PAV amide I (r4p) x14
PAV amide II/PAV proteins (r5p) x15
PAV amide I/PAV NA II (r6p) x16
PAV amide II/PAV NA II (r7p) x17
PAV amide I/PAV NA I (r8p) x18
PAV NA II/PAV NA I (r9p) x19
PAV amide I/PAV carbohydrates (r10p) x20
PAV amide II/PAV carbohydrates (r11p) x21
PAV amide I/PAV glycogen (r12p) x22
PAV proteins/PAV glycogen (r13p) x23
PAV NA II/PAV glycogen (r14p) x24
PAV carbohydrates/PAV NA I (r15p) x25
PAV carbohydrates/PAV Glycogen (r16p) x26
PAV proteins/PAV NA II (r17p) x27
PAV proteins /PAV carbohydrates (r18p) x28
PAV NA II/PAV carbohydrates (r19p) x29
PAV amide II/PAV glycogen (r20p) x30
PAV NA I/PAV glycogen (r21p) x31
Height of slope (h1s) x32
Figure 3 The conventional MLP networks.
Intelligent classiﬁcation of cervical pre-cancerous cells based on the FTIR spectra 65g. CA amide II/CA NA II
h. CA protein/CA NA II
i. CA amide I/CA NA I
j. CA NA II/CA NA I
3. Determine the height of slope between amide I and
amide II through the following steps:
i. Calculate the peak absorbance value of amide I.
ii. Calculate the peak absorbance value of amide II.
iii. Choose the smallest peak absorbance value between (i)
and (ii), then denote it as Ax.
iv. Calculate the peak absorbance value in wavenumber
1580 cm1.
v. Calculate the height of slope between amide I and amide
II according to Eq. (3).
HðxÞ ¼ Ax  A1580; x 2 R ð3Þ
where H(x) is the height of the slope between amide I and
amide II band, Ax and A1580 are absorbance values for amide
I or amide II band which have the minimum value, and absor-
bance value for the band at 1580 cm1, respectively.
In the previous study done by El-tawil et al. [34], only ﬁve
ratios of the peak absorbance value (i.e. glycogen/NA I, NA I/
carbohydrates, NA I/amide II, proteins/amide I, and NA I/
proteins) were investigated to differentiate the different types
of cervical cell spectra. In this work, after applying the pro-
posed PCABFE algorithm, 32 new features (i.e. 10 features
from the ratio of the corrected area (r1c–r10c), 21 features from
the ratio of peak absorbance value (r1p–r21p), and 1 feature
from the height of slope (h1s) between amide I and amide II
band) are proposed as features for differentiating between nor-
mal, LSIL, and HSIL cells. The proposed features are listed in
Table 3.
4. Intelligent classiﬁcation
Generally, all of the proposed features in Section 3 could be
used as the input data of ANN but irrelevant or unrelated fea-
tures could deteriorate the generalized performances of ANN
due to the large dimensionality problem [39]. Thus, in this
study, a discriminant analysis (DA) is used as a tool for feature
selection to determine the dominant features (i.e. to eliminate
the noisy and unwanted and/or insigniﬁcant features). For this
purpose, both the univariate and multivariate tests from the
Ward’s Linkage method are employed. The univariate test is
a test of equality of a group means of individual features. This
test is used to investigate the p-value distribution of the fea-
tures. The features with the p-value distribution less than 5%
are said to have high impact on the classiﬁcation process.
Thus, the null hypothesis is rejected for features with p-value
distribution more than 5%. The features are insigniﬁcant for
the classiﬁcation purpose. In the multivariate test, all tested
features must fulﬁll certain tolerance criteria. The features
must obtain at least 0.1 for tolerance value. Failing to fulﬁll
the criteria implies insigniﬁcant features. In addition, the DA
can also be used to classify the cervical pre-cancerous stages
into normal, LSIL, and HSIL based on the obtained dominant
features from the univariate and multivariate tests.
In recent years, the most common ANN used for pattern
recognition and classiﬁcation has been the MLP network
[40,41]. The MLP network is a feed forward artiﬁcial neural
network model which consists of three main layers namelythe input layer, hidden layer, and output layer [14]. As shown
in Fig. 3, the output of the MLP network with m outputs and
nh hidden nodes can be expressed by Eq. (4):
y^kðtÞ ¼
Xnh
j¼1
w2jkF
Xni
i¼1
w1ijm
0
i ðtÞ þ b1j
" #
; for 1 6 j 6 nh and 1 6 k 6 m ð4Þ
where w1ij and w
2
jk denote the weights of the connection between
the input and hidden layers and the connection between the
hidden and output layers, respectively. m0i and b
1
j denote the
66 Y. Jusman et al.inputs and the thresholds in hidden nodes, respectively; ni and
nh are the number of input nodes and hidden nodes respec-
tively, and ﬁnally F(Æ) is an activation function that is normally
selected as a sigmoidal function.
However, the MLP network is a highly non-linear neural
network. In a linear system case, the system has to be approx-
imated using the non-linear MLP network model. However,
modeling a linear system using a non-linear model can never
be better than using a linear model [42], [43].
To solve the limitation, the MLP was modiﬁed by Mashor
(2000) which is called the Hybrid Multilayered Perceptron
(HMLP) network [44]. The improvement was proposed to-
gether with a modiﬁed version of the recursive prediction error
algorithm called the Modiﬁed Recursive Prediction Error
(MRPE) as the training algorithm. The HMLP network allows
the network inputs to be connected directly to the output
nodes via some weighted connections to form a linear model,
parallel with the non-linear original MLP model as shown in
Fig. 4. The input layer of the HMLP network acts as a data
holder that distributes the input to the hidden layer and output
layer. The outputs from the hidden layer then become the in-
puts to the output layer and the last layer acts as the network’s
output layer.
The additional linear input connections do not signiﬁcantly
increase the complexity of the HMLP network since the con-
nections are linear. In fact, by using the linear input connec-
tions, the required number of hidden nodes could be
reduced, which will also reduce the computational load. It
has been proven that the HMLP network is more efﬁcient
and provides a signiﬁcant improvement in the accuracy rates
and MSE as compared to the standard MLP network [44].
As shown in Fig. 4, for the HMLP network with m output
nodes, nh hidden nodes, and ni input nodes, the output of
the kth neuron, y^kðtÞ, in the output layer is given by Eq. (5):
y^kðtÞ ¼
Xnh
j¼1
w2jkF
Xn1
i¼1
w1ijm
0
i ðtÞ þ b1j
 !
þ
Xn1
i¼0
wlikm
0
i ðtÞ; for 1
6 j 6 nh and 1 6 k 6 m ð5Þ
where w1ik denotes the weights of extra connections between the
input and output layers. The weights w1ij, w
2
jk, w
1
ik, and thresh-
old b1j are unknown and should be selected to minimize the
prediction error deﬁned in Eq. (6):Figure 4 The HMLP networks.ekðtÞ ¼ ykðtÞ  y^kðtÞ ð6Þ
where yk(t) and yk(t) are the actual and network outputs,
respectively. Detail explanation on the HMLP network and
the MRPE algorithm as the training algorithm can be found
in [44].5. Results and discussions
The effectiveness of the proposed automatic cervical pre-can-
cerous cells’ screening system is evaluated in this section. For
an evaluation of the automatic feature extraction performance,
a correlation test approach is used to determine the capability
of the proposed PCABFE algorithm as compared to the man-
ual extraction by human expert using the FTIR software.
For the intelligent diagnostic, this study employs a 10-fold
cross validation method to arrange the number of spectral data
for training and testing sets. Details on the said 10-fold cross
validation method are highlighted in [45]. In this method, the
data are partitioned into 10 sized segments or folds. Each fold
consists of 59 normal, 15 LSIL, and 4 HSIL. Ten iterations of
training and testing are performed. In each iteration, a differ-
ent fold of the data is held-out for testing while the remaining 9
folds are used for training. The testing accuracy result of the
HMLP trained with the MRPE is compared with the MLP
trained with the LM, the MLP trained with the BR, and the
MLP trained with the SCG networks. The performance com-
parison is done based on accuracy, sensitivity, speciﬁcity, false
negative and false positive as deﬁned by Eqs. (7)–(11),
respectively.
Accuracy ¼ ðTPþ TNÞ
Total data
% ð7Þ
Sensitiity ¼ TPðTPþ FNÞ% ð8Þ
Specificity ¼ TNðFPþ TNÞ% ð9Þ
False positie rate ¼ FPðFPþ TNÞ% ¼ 1 Specificity ð10Þ
False negatie rate ¼ FNðTPþ FNÞ% ¼ 1 Sensitiity ð11Þ
False positive (FP) is obtained when the normal outcome is
incorrectly classiﬁed as abnormal. False negative (FN) is ob-
tained when the abnormal outcome is incorrectly classiﬁed as
normal. True positives (TP) and true negatives (TN) are ob-
tained when the abnormal and normal outcomes are correctly
classiﬁed as they are.
5.1. Features extraction performance
Table 4 tabulates the correlation test results between manual
features extractions using the FTIR software and the proposed
PCABFE algorithm. The primary features; i.e. the peak absor-
bances, the corrected areas, and the height of slope show very
strong linear relationship (i.e. correlation test more than 0.95)
with those extracted manually using the FTIR software. Partic-
ularly, the corrected area almost reaches 1.00 for the correla-
tion test. Thus, a total of 32 secondary features generated
Table 6 Results for multivariate test with variables failing
tolerance test.
Features Tolerance Minimum Tolerance
x19(r9p) 0.004 0.000
x21(r11p) 0.001 0.001
x23(r13p) 0.002 0.001
x24(r14p) 0.006 0.001
x26(r16p) 0.014 0.001
x27(r17p) 0.005 0.000
x28(r18p) 0.001 0.001
x29(r19p) 0.005 0.001
x30(r20p) 0.000 0.000
x31(r21p) 0.011 0.001
Table 4 Result of correlation test.
Primary features of cervical cell spectra Correlation value
Peak absorbance of amide I 0.9965
Peak absorbance of amide II 0.9895
Peak absorbance of symmetric CH bending modes in proteins 0.9542
Peak absorbance of asymmetric PO34 stretching mode in nucleic acids 0.9892
Peak absorbance of C–O stretching mode in the carbohydrates 0.9897
Peak absorbance of symmetric PO34 stretching mode in nucleic acids 0.9757
Peak absorbance of glycogen 0.9649
Corrected area of amide I 0.9943
Corrected area of amide II 0.9919
Corrected area of symmetric CH bending modes in proteins 0.9976
Corrected area of asymmetric PO34 stretching mode in nucleic acids 0.9941
Corrected area of symmetric PO34 stretching mode in nucleic acids 0.9952
Height of slope 0.9967
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tionship as well. This test conﬁrms the effectiveness of the pro-
posed PCABFE algorithm to extract the features of the cervical
cell spectra which is comparable to the manual extraction by
the FTIR software.
5.2. Intelligent classiﬁcation performance
Having the 32 extracted features, the next step undertaken was
to determine the useful and important features using feature
selection techniques. The selection of features with relevant
information used as input data for a neural network is a crucial
step for the network effective learning [46]. By using the discrim-
inant analysis, unrelated features are discarded. The unrelated
features caused the deterioration of the general performance
of the neural networks.
5.2.1. Features selection
In the current study, all the 32 features of 780 cervical cell spec-
tra with its 3 main groups are tabulated in the Microsoft Excel
spreadsheet. Then, the discriminant analysis using the SPSS
software version 14 is used as a feature selection tool to deter-
mine the dominant features.Table 5 Results for univariate test for 32 features and its p-
value distribution (The bold values represent the insigniﬁcant
features).
Features P value distribution Features P value distribution
x1(r1c) 0.000 x17(r7p) 0.000
x2(r2c) 0.000 x18(r8p) 0.000
x3(r3c) 0.005 x19(r9p) 0.000
x4(r4c) 0.000 x20(r10p) 0.000
x5(r5c) 0.000 x21(r11p) 0.000
x6(r6c) 0.000 x22(r12p) 0.007
x7(r7c) 0.000 x23(r13p) 0.000
x8(r8c) 0.000 x24(r14p) 0.000
x9(r9c) 0.000 x25(r15p) 0.000
x10(r10c) 0.000 x26(r16p) 0.000
x11(r1p) 0.000 x27(r17p) 0.000
x12(r2p) 0.000 x28(r18p) 0.181
x13(r3p) 0.001 x29(r19p) 0.003
x14(r4p) 0.000 x30(r20p) 0.516
x15(r5p) 0.000 x31(r21p) 0.000
x16(r6p) 0.000 x32(h1s) 0.000Table 5 shows the results of the univariate test for the 32 fea-
tures. Based on the results, the features x28(r18p) and x30(r20p)
have low impact for the classiﬁcation process with its p-value
distributionmore than 5%.The other features showhigh impact
with p-value distribution less than 5%.Hence, null hypothesis isTable 7 The 22 dominant features and its discriminant
coefﬁcient.
Features Coeﬃcient Features Coeﬃcient Features Coeﬃcient
x1(r1c) 1.982 x9(r9c) 2.376 x17(r7p) 3.021
x2(r2c) 2.309 x10(r10c) 1.754 x18(r8p) 0.111
x3(r3c) 0.995 x11(r1p) 1.952 x20(r10p) 0.346
x4(r4c) 1.098 x12(r2p) 413.298 x22(r12p) 12.526
x5(r5c) 9.053 x13(r3p) 1.878 x25(r15p) 4.267
x6(r6c) 4.507 x14(r4p) 0.334 x32(h1s) 0.703
x7(r7c) 1.900 x15(r5p) 1.197 Constant 1.523
x8(r8c) 3.057 x16(r6p) 1.423
Table 8 Centroid for each cervical cell group.
Cervical pre-cancerous cells Group centroid
LSIL 2.479
HSIL 0.146
Normal 0.533
Table 9 Comparison of optimum diagnostic performance for the HMLP, the MLP networks, and the DA classiﬁcation.
Classiﬁer HMLP with MRPE DA MLP with LM MLP with BR MLP with SCG
Accuracy 97.4 85.4 79.5 70.5 47.4
Sensitivity 100 92.5 93.2 84.06 85.5
Speciﬁcity 95.2 71.0 78.9 88.89 100
False negative 0.0 7.5 6.8 15.94 14.5
False positive 4.8 29.0 21.1 11.11 0.0
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other 30 features. Based on the multivariate test, Table 6 tabu-
lates the failed features for the tolerance test. Less than 0.1 tol-
erance value indicates that multicolinearity has occurred. From
Table 6, a total of 10 features that produce low impact or are
deemed insigniﬁcant for the classiﬁcation process will be ex-
cluded as input features in the classiﬁcation process.
From the univariate and multivariate tests, 22 dominant
features are found namely x1(r1c), x2(r2c), x3(r3c), x4(r4c),
x5(r5c), x6(r6c), x7(r7c), x8(r8c), x9(r9c), x10(r10c), x11(r1p),
x12(r2p), x13(r3p), x14(r4p), x15(r5p), x16(r6p), x17(r7p), x18(r8p),
x20(r10p), x22(r12p), x25(r15p), and x32(h1s). These 22 dominant
features give their own discriminant coefﬁcient from the DA
for the classiﬁcation process as tabulated in Table 7.
5.2.2. Cervical pre-cancerous classiﬁcation performance
In addition to determine the dominant features causing high
impact, the discriminant analysis is also able to classify the
data into groups based on the discriminant coefﬁcient of the
dominant features. Thus, the DA is also employed in this study
to classify the pre-cancerous stages of cervical cells together
with the HMLP trained with the MRPE, the MLP trained with
the LM, the MLP trained with the BR, and the MLP trained
with the SCG. Based on the discriminant coefﬁcient of the
dominant features as tabulated in Table 7, the equation for
the DA to classify the cervical pre-cancer is given by:
Zpc ¼ 1:982x1 þ 2:309x2 þ 0:995x3 þ 1:098x4 þ 9:053x5
 4:507x6 þ 1:900x7  3:057x8  2:376x9
þ 1:754x10 þ 1:952x11  413:298x12  1:878x13
þ 0:334x14 þ 1:197x15  1:423x16  3:021x17
þ 0:111x18  0:346x19 þ 12:526x20  4:267x21
 0:703x22 þ 1:523 ð12Þ
Based on the Zpc value, the group mean called the centroid is
determined. The centroid (mid-point) for each cervical cell
group is shown in Table 8. Then, the separation point is deter-
mined to identify the classiﬁcation range of each cervical pre-
cancerous cell.
The separation points between the groups are deﬁned as
follows:
For the LSIL and normal cells, the separation point is:
LSILjNormal ¼ ð2:479Þ þ ð0:533Þ
2
 
¼ 1:507 ð13Þ
The separation point between normal and HSIL cells is:
NormaljHSIL ¼ ð0:533Þ þ ð0:146Þ
2
 
¼ 0:194 ð14ÞAs shown by Eqs. (13) and (14), the range less than 1.507, be-
tween 1.507 and 0.194, and greater than 0.194 represent
LSIL, normal, and HSIL cervical cells, respectively.
Table 9 tabulates the results of the classiﬁcation obtained.
From Table 9, it is shown that the HMLP trained with the
MRPE produces the best testing accuracy performance with
accuracy 97.4% which is followed by the DA, the MLP trained
with the LM, the MLP trained with the BR, and the MLP
trained with the SCG with the accuracy of 85.4%, 79.5%,
70.5%, and 47.4%, respectively. In addition, as shown in
Table 9, the HMLP is conﬁrmed as the best intelligent classiﬁ-
cation tool due to higher percentage of sensitivity and speciﬁc-
ity and lower percentage of false negative and false negative
rates. Particularly, the sensitivity and false negative results pro-
duced are 100% and 0.0%, respectively. It proves that the
HMLP network with the proposed 22 dominant features from
780 spectra has the high capability to classify all abnormal cer-
vical cells correctly. Furthermore, the results obtained also
favor the HMLP network in classifying the normal cells with
the speciﬁcity of 95.2%; the highest percentage as compared
to others. The HMLP network also keeps the low rate of false
positive (i.e. 4.8%).7. Conclusion
In conclusion, the PCABFE algorithm is able to extract fea-
tures of cervical pre-cancerous cells. HMLP network trained
with the MRPE algorithm could classify these cells into nor-
mal, LSIL, and HSIL cells. The analyses show 97.4%, 100%,
95.2%, 0.0%, and 4.8% of accuracy, sensitivity, speciﬁcity,
false negative, and false positive values, respectively. Although
these results are encouraging, further investigations are needed
before it could be used as screening tools for cervical cancer.Acknowledgements
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